Jin Medical International Ltd. (ZJYL) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
ZJYL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ZJYL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 40.4% | 15.5% | 15.6% |
| 2023 | 34.2% | 14.5% | 14.5% |
| 2022 | 32.3% | 11.1% | 14.1% |
| 2021 | 30.6% | 12.7% | 12.7% |
| 2020 | 34.0% | 14.5% | 13.6% |
Download Data
Export ZJYL earnings history in CSV or JSON format
Free sign-in required to download data
Jin Medical International Ltd. (ZJYL) Earnings Overview
As of May 9, 2026, Jin Medical International Ltd. (ZJYL) reported trailing twelve-month net income of $5M, reflecting +18.7% year-over-year growth. The company earned $0.03 per diluted share over the past four quarters, with a net profit margin of 15.6%.
Looking at the long-term picture, ZJYL's 5-year EPS compound annual growth rate (CAGR) stands at +20.9%, indicating exceptional earnings growth. The company achieved its highest annual net income of $4M in fiscal 2018.
Jin Medical International Ltd. maintains industry-leading profitability with a gross margin of 40.4%, operating margin of 15.5%, and net margin of 15.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including MPWR ($616M net income, 22.1% margin), NVCR (-$173M net income, -20.8% margin), LFUS (-$40M net income, -3.0% margin), ZJYL has room to improve margins relative to the peer group. Compare ZJYL vs MPWR →
ZJYL Earnings vs Peers
Earnings metrics vs comparable public companies
ZJYL Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $4M | +27.7% | $4M | $0.02 | 15.6% | 15.5% |
| 2023 | $3M | +6.3% | $3M | $0.02 | 14.5% | 14.5% |
| 2022 | $3M | +2.8% | $2M | $0.02 | 14.1% | 11.1% |
| 2021 | $3M | +19.3% | $3M | $0.01 | 12.7% | 12.7% |
| 2020 | $2M | -39.5% | $2M | $0.01 | 13.6% | 14.5% |
| 2019 | $4M | -0.9% | $4M | $0.01 | 17.9% | 21.6% |
| 2018 | $4M | - | $4M | $0.01 | 17.6% | 20.2% |
See ZJYL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZJYL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZJYL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
Is ZJYL growing earnings?
ZJYL EPS is $0.03, with earnings growth accelerating to +18.7%. This exceeds the 5-year CAGR of +20.9%. TTM net income reached $5M.
What are ZJYL's profit margins?
Jin Medical International Ltd. net margin is +15.6%, with operating margin at +15.5%. Above-average margins indicate pricing power.
How consistent are ZJYL's earnings?
ZJYL earnings data spans 2018-2024. The accelerating earnings trend is +18.7% YoY. Historical data enables comparison across business cycles.